Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the RSV fusion protein

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8853204
SERIAL NO

10593666

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A pharmaceutical composition which comprises a pharmaceutically acceptable carrier or diluent and: (a) an inhibitor of the RSV fusion protein; and (b) a benzodiazepine derivative capable of inhibiting RSV replication is found to be highly active against RSV.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ARROW THERAPEUTICS LIMITEDBRITANNIA HOUSE 7 TRINITY STREET LONDON SE1 1DB

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alber, Dagmar London, GB 5 78
Carter, Malcolm London, GB 14 245
Chambers, Phil London, GB 3 79
Dowdell, Verity London, GB 5 137
Henderson, Elisa London, GB 6 155
Kelsey, Richard London, GB 11 187
Powell, Kenneth London, GB 4 55
Taylor, Debra London, GB 3 115
Tyms, Stan London, GB 3 79
Wilson, Lara London, GB 3 115

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 7, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00